Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is still down nearly 50% in 2025. However, the stock is now trading near its 52-week low and is a discount to itself in several metrics. Analysts believe NVO stock has significant upside, so is this a buying opportunity?
To answer that question requires a realistic, long-term outlook. That’s not something many investors like to hear. In the short term, some factors could weigh down the stock and even send it lower. However, if you’re looking for value in a volatile space, NVO starts to have some appeal.
